|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.21 USD | -2.30% |
|
-6.38% | -30.78% |
| 06-02 | Daxor Says Received US Patent for Remote Blood Volume Monitor Technology | MT |
| 04-26 | 5,061,267 Common Stock of Daxor Corporation are subject to a Lock-Up Agreement Ending on 27-APR-2026. | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 3.76% | 4.01% | - | - | - | - | - | 4.72B | |
| 6.27% | 6.38% | - | - | - | - | - | 3.36B | |
| 7.3% | 7.65% | 14.16x | 1.08x | 12.8x | - | 15.22x | 3.3B | |
| 15.48% | 14.75% | -30.97x | 0.57x | 8.55x | - | 20.68x | 3.04B | |
| Average | 8.2% | 8.2% | -8.40x | 0.83x | 10.68x | 17.95x | 3.61B | ||
| Weighted average by Cap. | 7.63% | 7.66% | -7.46x | 0.84x | 10.76x | 17.84x |
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Sector Daxor Corporation
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
